For patients with relapsing-remitting MS (RRMS), there is no excess mortality in the first 10 years of the disease, and from a current age of 70 years, mortality rates are the same regardless of age at clinical onset of MS, researchers have reported.
News News Daily digests from key neurology conferences, written by on-site medical journalists.